Preventing blindness by improving retinal therapy with AI
deepeye has raised $2.7M in total funding. The most recent round was Seed. The last funding was announced in November 2023.
deepeye's investors include YZR Capital, Bayern Kapital, Arve Capital, Springboard Health Angels.
deepeye is headquartered in Munich, Germany.
Preventing blindness by improving retinal therapy with AI
deepeye is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"deepeye — Funding & Investors." VCBacked, November 7, 2023, https://www.vcbacked.co/company/deepeye. Accessed July 19, 2026.
VCBacked. (2023). deepeye — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/deepeye
{{cite web |title=deepeye — Funding & Investors |url=https://www.vcbacked.co/company/deepeye |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated